Gómez-Peralta, F.; Menéndez, E.; Conde, S.; Abellán-Galiana, P.; Brito, M.; Beléndez, M.; Pérez, A., on behalf of SED1 Study Investigators.
Metabolic and Clinical Outcomes in Type 1 Diabetes in the COVID-19 Pre- and Post-Vaccination Periods in Spain: The COVID-SED1 Study. J. Clin. Med. 2024, 13, 1922.
https://doi.org/10.3390/jcm13071922
AMA Style
Gómez-Peralta F, Menéndez E, Conde S, Abellán-Galiana P, Brito M, Beléndez M, Pérez A on behalf of SED1 Study Investigators.
Metabolic and Clinical Outcomes in Type 1 Diabetes in the COVID-19 Pre- and Post-Vaccination Periods in Spain: The COVID-SED1 Study. Journal of Clinical Medicine. 2024; 13(7):1922.
https://doi.org/10.3390/jcm13071922
Chicago/Turabian Style
Gómez-Peralta, Fernando, Edelmiro Menéndez, Santiago Conde, Pablo Abellán-Galiana, Miguel Brito, Marina Beléndez, and Antonio Pérez on behalf of SED1 Study Investigators.
2024. "Metabolic and Clinical Outcomes in Type 1 Diabetes in the COVID-19 Pre- and Post-Vaccination Periods in Spain: The COVID-SED1 Study" Journal of Clinical Medicine 13, no. 7: 1922.
https://doi.org/10.3390/jcm13071922
APA Style
Gómez-Peralta, F., Menéndez, E., Conde, S., Abellán-Galiana, P., Brito, M., Beléndez, M., & Pérez, A., on behalf of SED1 Study Investigators.
(2024). Metabolic and Clinical Outcomes in Type 1 Diabetes in the COVID-19 Pre- and Post-Vaccination Periods in Spain: The COVID-SED1 Study. Journal of Clinical Medicine, 13(7), 1922.
https://doi.org/10.3390/jcm13071922